Pharmaceutical

Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, announces that the U.S. Patent and Trademark Office (USPTO) has granted patent application number 15/099,977 titled, “Ether and Alkyl Phospholipid Compounds for Treating Cancer and Imaging Detection of Cancer Stem Cells.” As quoted in the press …

Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, announces that the U.S. Patent and Trademark Office (USPTO) has granted patent application number 15/099,977 titled, “Ether and Alkyl Phospholipid Compounds for Treating Cancer and Imaging Detection of Cancer Stem Cells.

As quoted in the press release:

This new patent enhances the coverage for the use of CLR 131 as a treatment for multiple cancers including gliomas, lung cancer, squamous cell carcinoma, renal cancer, melanoma, colorectal cancer, ovarian cancer, prostate cancer, breast cancer, and pancreatic cancer including cancer stem cells.

“This patent expands protection for our PDC compounds across a number of significant cancers and importantly cancer stem cells. The ability of our PDC pipeline products, including CLR 131, to target both cancer cells and cancer stem cells for difficult to treat tumors could provide improved therapeutic benefits,” stated Jim Caruso, chief executive officer of Cellectar Biosciences. “The patent also provides further coverage for CLR 131’s use in underserved pediatric diseases such as glioma, an indication that we plan to advance into the clinic in the second half of this year.”

Click here to read the full press release.

MARKETS

Markets
TSX19666.75+210.04
TSXV641.79+6.38
DOW32675.78+146.15
S&P 5004108.32+35.89
NASD12292.44+129.85
ASX6889.70+66.50

COMMODITIES

Commodities
Gold1766.88+12.15
Silver20.29+0.34
Copper3.57+0.09
Palladium2133.50+57.50
Platinum902.50+13.49
Oil100.44+4.02
Heating Oil3.66+0.05
Natural Gas8.16+0.03

DOWNLOAD FREE REPORTS

×